Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-06-04

FDA Approved: WEGOVY — Original Application (Novo Nordisk)

View source ↗

Summary

The FDA approved Wegovy (semaglutide) in an original application for chronic weight management in adults with obesity or overweight with weight-related conditio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • WEGOVY (Semaglutide)

Snippet

ORIG AP for WEGOVY (SEMAGLUTIDE)